• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺陷型鞘氨醇 1-磷酸受体 1(S1P1)磷酸化加重 TH17 介导的自身免疫性神经炎症。

Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.

机构信息

1] Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, California, USA. [2] Graduate Program in Immunology, Division of Medical Sciences, Harvard Medical School, Boston, Massachusetts, USA. [3].

出版信息

Nat Immunol. 2013 Nov;14(11):1166-72. doi: 10.1038/ni.2730. Epub 2013 Sep 29.

DOI:10.1038/ni.2730
PMID:24076635
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4014310/
Abstract

Sphingosine 1-phosphate (S1P) signaling regulates lymphocyte egress from lymphoid organs into systemic circulation. The sphingosine phosphate receptor 1 (S1P1) agonist FTY-720 (Gilenya) arrests immune trafficking and prevents multiple sclerosis (MS) relapses. However, alternative mechanisms of S1P-S1P1 signaling have been reported. Phosphoproteomic analysis of MS brain lesions revealed S1P1 phosphorylation on S351, a residue crucial for receptor internalization. Mutant mice harboring an S1pr1 gene encoding phosphorylation-deficient receptors (S1P1(S5A)) developed severe experimental autoimmune encephalomyelitis (EAE) due to autoimmunity mediated by interleukin 17 (IL-17)-producing helper T cells (TH17 cells) in the peripheral immune and nervous system. S1P1 directly activated the Jak-STAT3 signal-transduction pathway via IL-6. Impaired S1P1 phosphorylation enhances TH17 polarization and exacerbates autoimmune neuroinflammation. These mechanisms may be pathogenic in MS.

摘要

鞘氨醇 1-磷酸(S1P)信号调节淋巴细胞从淋巴器官输出到全身循环。鞘氨醇磷酸受体 1(S1P1)激动剂 FTY-720(Gilenya)阻断免疫细胞迁移,预防多发性硬化症(MS)复发。然而,已经报道了 S1P-S1P1 信号的其他机制。对 MS 脑损伤的磷酸蛋白质组学分析显示 S1P1 在 S351 上发生磷酸化,S351 是受体内化的关键残基。由于外周免疫和神经系统中白细胞介素 17(IL-17)产生的辅助性 T 细胞(TH17 细胞)介导的自身免疫,携带编码磷酸化缺陷受体(S1P1(S5A))的 S1pr1 基因突变的小鼠发生严重的实验性自身免疫性脑脊髓炎(EAE)。S1P1 通过白细胞介素 6(IL-6)直接激活 Jak-STAT3 信号转导途径。S1P1 磷酸化受损增强了 TH17 极化并加重了自身免疫性神经炎症。这些机制可能与 MS 的发病机制有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a21/4014310/045d7f937848/nihms521577f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a21/4014310/bbebc9c93ec7/nihms521577f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a21/4014310/df16298c9cb9/nihms521577f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a21/4014310/d14fb4b03442/nihms521577f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a21/4014310/4a141ce55fa8/nihms521577f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a21/4014310/045d7f937848/nihms521577f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a21/4014310/bbebc9c93ec7/nihms521577f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a21/4014310/df16298c9cb9/nihms521577f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a21/4014310/d14fb4b03442/nihms521577f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a21/4014310/4a141ce55fa8/nihms521577f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a21/4014310/045d7f937848/nihms521577f6.jpg

相似文献

1
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.缺陷型鞘氨醇 1-磷酸受体 1(S1P1)磷酸化加重 TH17 介导的自身免疫性神经炎症。
Nat Immunol. 2013 Nov;14(11):1166-72. doi: 10.1038/ni.2730. Epub 2013 Sep 29.
2
Myeloid sphingosine-1-phosphate receptor 1 is important for CNS autoimmunity and neuroinflammation.髓鞘鞘氨醇-1-磷酸受体 1 对于中枢神经系统自身免疫和神经炎症很重要。
J Autoimmun. 2019 Dec;105:102290. doi: 10.1016/j.jaut.2019.06.001. Epub 2019 Jun 12.
3
S1P deletion differentially affects TH17 and Regulatory T cells.S1P 缺失对 TH17 和调节性 T 细胞有不同的影响。
Sci Rep. 2017 Oct 10;7(1):12905. doi: 10.1038/s41598-017-13376-2.
4
FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous system.FTY720(芬戈莫德)在多发性硬化症中的作用:在免疫系统和中枢神经系统中的治疗效果。
Br J Pharmacol. 2009 Nov;158(5):1173-82. doi: 10.1111/j.1476-5381.2009.00451.x. Epub 2009 Oct 8.
5
HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation.高密度脂蛋白结合的1-磷酸鞘氨醇抑制淋巴细胞生成和神经炎症。
Nature. 2015 Jul 16;523(7560):342-6. doi: 10.1038/nature14462. Epub 2015 Jun 8.
6
Morpholino Analogues of Fingolimod as Novel and Selective S1P Ligands with In Vivo Efficacy in a Mouse Model of Experimental Antigen-Induced Encephalomyelitis.芬戈莫德类似物作为新型和选择性 S1P 配体,在实验性自身免疫性脑脊髓炎小鼠模型中具有体内疗效。
Int J Mol Sci. 2020 Sep 4;21(18):6463. doi: 10.3390/ijms21186463.
7
ST-2191, an Anellated Bismorpholino Derivative of Oxy-Fingolimod, Shows Selective S1P Agonist and Functional Antagonist Potency In Vitro and In Vivo.ST-2191,一种氧芬戈莫德的稠合双吗啉衍生物,在体外和体内显示出选择性 S1P 激动剂和功能拮抗剂活性。
Molecules. 2021 Aug 24;26(17):5134. doi: 10.3390/molecules26175134.
8
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.高密度脂蛋白结合的1-磷酸鞘氨醇作为内皮细胞受体S1P1的偏向性激动剂,以限制血管炎症。
Sci Signal. 2015 Aug 11;8(389):ra79. doi: 10.1126/scisignal.aaa2581.
9
Sphingosine-1-phosphate (S1P) displays sustained S1P1 receptor agonism and signaling through S1P lyase-dependent receptor recycling.鞘氨醇-1-磷酸(S1P)通过 S1P 裂解酶依赖性受体再循环,显示出持续的 S1P1 受体激动作用和信号转导。
Cell Signal. 2014 Jul;26(7):1576-88. doi: 10.1016/j.cellsig.2014.03.029. Epub 2014 Apr 2.
10
AKP-11 - A Novel S1P1 Agonist with Favorable Safety Profile Attenuates Experimental Autoimmune Encephalomyelitis in Rat Model of Multiple Sclerosis.AKP-11——一种具有良好安全性的新型S1P1激动剂可减轻多发性硬化症大鼠模型中的实验性自身免疫性脑脊髓炎。
PLoS One. 2015 Oct 29;10(10):e0141781. doi: 10.1371/journal.pone.0141781. eCollection 2015.

引用本文的文献

1
The critical roles of bioactive sphingolipids in inflammation.生物活性鞘脂在炎症中的关键作用。
J Biol Chem. 2025 Jul 11;301(8):110475. doi: 10.1016/j.jbc.2025.110475.
2
Sphingosine 1-phosphate receptor 1 modulators exert neuroprotective effects in central nervous system disorders.1-磷酸鞘氨醇受体1调节剂在中枢神经系统疾病中发挥神经保护作用。
Front Pharmacol. 2025 May 14;16:1516991. doi: 10.3389/fphar.2025.1516991. eCollection 2025.
3
Ex Vivo Overactivation of Lymphocyte Subsets in Fibrotic Hypersensitivity Pneumonitis Is Blunted by a Sphingosine-1-Phosphate Receptor Ligand.

本文引用的文献

1
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.从那他珠单抗转换为芬戈莫德治疗后出现的肿胀性多发性硬化症。
Mult Scler. 2012 Nov;18(11):1650-2. doi: 10.1177/1352458512463768.
2
Tumefactive multiple sclerosis lesions under fingolimod treatment.芬戈莫德治疗下的肿胀性多发性硬化病变
Neurology. 2012 Nov 6;79(19):2000-3. doi: 10.1212/WNL.0b013e3182735cb3. Epub 2012 Oct 3.
3
Fingolimod and multiple sclerosis: four cautionary tales.芬戈莫德与多发性硬化症:四个警示故事。
纤维化性过敏性肺炎中淋巴细胞亚群的体外过度激活被1-磷酸鞘氨醇受体配体抑制。
Int J Mol Sci. 2025 Mar 29;26(7):3197. doi: 10.3390/ijms26073197.
4
Mettl3-mA-NPY axis governing neuron-microglia interaction regulates sleep amount of mice.Mettl3介导的NPY轴调控神经元与小胶质细胞的相互作用,进而调节小鼠的睡眠量。
Cell Discov. 2025 Feb 4;11(1):10. doi: 10.1038/s41421-024-00756-y.
5
Machine learning models to identify lead compound and substitution optimization to have derived energetics and conformational stability through docking and MD simulations for sphingosine kinase 1.通过对接和分子动力学模拟,利用机器学习模型识别鞘氨醇激酶1的先导化合物并进行取代优化,以获得能量学和构象稳定性。
Mol Divers. 2025 Aug;29(4):2945-2977. doi: 10.1007/s11030-024-10997-4. Epub 2024 Oct 17.
6
Therapeutic Plasma Exchange and Multiple Sclerosis Dysregulations: Focus on the Removal of Pathogenic Circulatory Factors and Altering Nerve Growth Factor and Sphingosine-1-Phosphate Plasma Levels.治疗性血浆置换与多发性硬化失调:聚焦于去除致病性循环因子及改变神经生长因子和血浆鞘氨醇-1-磷酸水平。
Curr Issues Mol Biol. 2023 Sep 25;45(10):7749-7774. doi: 10.3390/cimb45100489.
7
Novel variants in CRB2 targeting the malfunction of slit diaphragm related to focal segmental glomerulosclerosis.靶向与局灶节段性肾小球硬化相关的裂孔隔膜功能障碍的CRB2新变体。
Pediatr Nephrol. 2024 Jan;39(1):149-165. doi: 10.1007/s00467-023-06087-6. Epub 2023 Jul 15.
8
Functional roles of sphingolipids in immunity and their implication in disease.鞘脂类在免疫中的功能作用及其在疾病中的意义。
Exp Mol Med. 2023 Jun;55(6):1110-1130. doi: 10.1038/s12276-023-01018-9. Epub 2023 Jun 1.
9
Molecular and neuroimmune pharmacology of S1P receptor modulators and other disease-modifying therapies for multiple sclerosis.鞘氨醇 1 受体调节剂及其他多发性硬化症治疗药物的分子神经免疫药理学
Pharmacol Ther. 2023 Jun;246:108432. doi: 10.1016/j.pharmthera.2023.108432. Epub 2023 May 4.
10
Update of cellular responses to the efferocytosis of necroptosis and pyroptosis.细胞对坏死性凋亡和焦亡细胞清除作用反应的最新进展。
Cell Div. 2023 Apr 9;18(1):5. doi: 10.1186/s13008-023-00087-6.
Neurology. 2012 Nov 6;79(19):1942-3. doi: 10.1212/WNL.0b013e3182735edf. Epub 2012 Oct 3.
4
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.CD47 在人类和小鼠自身免疫性脑炎症中的类 Janus 相反作用。
J Exp Med. 2012 Jul 2;209(7):1325-34. doi: 10.1084/jem.20101974. Epub 2012 Jun 25.
5
Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway.鞘氨醇-1-磷酸通过 S1PR2/STAT3 信号通路增强萎缩肌肉中的卫星细胞激活。
PLoS One. 2012;7(5):e37218. doi: 10.1371/journal.pone.0037218. Epub 2012 May 14.
6
Relapse and disability outcomes in patients with multiple sclerosis treated with fingolimod: subgroup analyses of the double-blind, randomised, placebo-controlled FREEDOMS study.在接受芬戈莫德治疗的多发性硬化症患者中的复发和残疾结局:FREEDOMS 双盲、随机、安慰剂对照研究的亚组分析。
Lancet Neurol. 2012 May;11(5):420-8. doi: 10.1016/S1474-4422(12)70056-X. Epub 2012 Apr 10.
7
Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.鞘氨醇-1-磷酸和淋巴细胞从淋巴器官迁出。
Annu Rev Immunol. 2012;30:69-94. doi: 10.1146/annurev-immunol-020711-075011. Epub 2011 Dec 5.
8
GRK2-dependent S1PR1 desensitization is required for lymphocytes to overcome their attraction to blood.GRK2 依赖性 S1PR1 脱敏对于淋巴细胞克服对血液的吸引力是必需的。
Science. 2011 Sep 30;333(6051):1898-903. doi: 10.1126/science.1208248.
9
A mechanistically novel, first oral therapy for multiple sclerosis: the development of fingolimod (FTY720, Gilenya).一种作用机制新颖的多发性硬化症口服一线疗法:芬戈莫德(FTY720,捷灵亚)的研发。
Discov Med. 2011 Sep;12(64):213-28.
10
Systemic augmentation of alphaB-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation.通过免疫调节,αB-晶体蛋白全身性增强在中风发作后 12 小时提供治疗益处。
Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13287-92. doi: 10.1073/pnas.1107368108. Epub 2011 Jul 26.